前往化源商城

Journal of Combinatorial Chemistry 2008-01-01

Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.

Marcio C Mancini, Alfredo Halpern

文献索引:J. Comb. Chem. 11(1) , 34-43, (2009)

全文:HTML全文

摘要

For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducibly make new, high quality, molecules with potential for biological activity. This article reports the successful achievement of this goal. Using previously rehearsed alkylating agents, students in a second semester organic chemistry laboratory performed a solid-phase combinatorial chemistry experiment in which they made 38 new analogs of the most potent member of a class of antimelanoma compounds. All compounds were made in duplicate, purified by silica gel chromatography, and characterized by NMR and LC/MS. As a continuing part of the Distributed Drug Discovery program, a virtual D(3) catalog based on this work was then enumerated and is made freely available to the global scientific community.

相关化合物

结构式 名称/CAS号 全部文献
氘代甲醇 结构式 氘代甲醇
CAS:811-98-3
芴甲氧羰酰氯(Fmoc-Cl) 结构式 芴甲氧羰酰氯(Fmoc-Cl)
CAS:28920-43-6
2-(三氟甲基)苄溴 结构式 2-(三氟甲基)苄溴
CAS:395-44-8
邻碘溴苄 结构式 邻碘溴苄
CAS:40400-13-3
邻溴溴苄 结构式 邻溴溴苄
CAS:3433-80-5
间溴溴苄 结构式 间溴溴苄
CAS:823-78-9
对碘溴苄 结构式 对碘溴苄
CAS:16004-15-2
间氟氯苄 结构式 间氟氯苄
CAS:456-42-8
3-三氟甲基氯苄 结构式 3-三氟甲基氯苄
CAS:705-29-3